Where Are All the AI Drugs?
Summary
The article examines why, despite significant investment and hype, artificial intelligence has yet to deliver major breakthroughs in drug discovery. It highlights that while AI shows promise in identifying potential drug candidates faster, translating these discoveries into approved, effective medicines remains a slow and complex process. This underscores the challenges of applying AI in highly regulated, scientifically demanding fields like pharmaceuticals.